As previously reported, Morgan Stanley downgraded Constellation Brands (STZ) to Equal Weight from Overweight with a price target of $202, down from $220. Given pressure from health/wellness, less younger age alcohol consumption than in prior generations, cannabis, competition, a more mature Constellation brand portfolio and muted category growth, the firm has increased concern over long-term beer growth, the analyst tells investors. However, the “already compressed” valuation “looks reasonable,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STZ:
- Constellation downgraded to Equal Weight from Overweight at Morgan Stanley
- Warren Buffett Pulls the Trigger on 2 Low-Yield Dividend Stocks — Here’s Why You Might Still Want to Ride His Coattail
- Constellation Brands Announces Executive Leadership Change
- Constellation Brands announces departure of Hermida, EVP, CG&SO
- Levi & Korsinsky LLP Notifies Shareholders of Constellation Brands, Inc.(STZ) of a Class Action Lawsuit and an Upcoming Deadline